J Zuckerman

Summary

Affiliation: University College London
Country: UK

Publications

  1. ncbi request reprint Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines and WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, Royal Free and University College Medical School, University College London, United Kingdom
    J Med Virol 78:169-77. 2006
  2. doi request reprint Hepatitis B immunisation in travellers: poor risk perception and inadequate protection
    Jane N Zuckerman
    WHO Collaborating Centre for Travel Medicine, The Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill St, London, NW3 2PF, UK
    Travel Med Infect Dis 6:315-20. 2008
  3. ncbi request reprint The place of accelerated schedules for hepatitis A and B vaccinations
    Jane Zuckerman
    Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK
    Drugs 63:1779-84. 2003
  4. pmc Recent developments: Travel medicine
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, London NW3 2PF
    BMJ 325:260-4. 2002
  5. ncbi request reprint Vaccination priorities in travel
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, University College London, London, UK
    BioDrugs 17:1-6. 2003
  6. ncbi request reprint Recombinant hepatitis B triple antigen vaccine: Hepacare
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, University College of London, UK
    Expert Rev Vaccines 1:141-4. 2002
  7. ncbi request reprint Hepatitis B vaccination in a school age population: a feasibility study
    Jane Zuckerman
    Academic Centre for Travel Medicine and Vaccines, WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, Royal Free and University College Medical School, London, United Kingdom
    J Med Virol 76:47-54. 2005
  8. ncbi request reprint Mutations of the surface protein of hepatitis B virus
    Jane N Zuckerman
    Research and Training in Travel Medicine, Royal Free and University College Medical School, University College London, London, UK
    Antiviral Res 60:75-8. 2003
  9. ncbi request reprint Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa
    D A Hughes
    Department of Academic Haematology, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK
    Heart 94:153-8. 2008
  10. ncbi request reprint Hearing improvement in patients with Fabry disease treated with agalsidase alfa
    D Hajioff
    Department of Otolaryngology, Royal Free Hospital, London, UK
    Acta Paediatr Suppl 92:28-30; discussion 27. 2003

Detail Information

Publications22

  1. ncbi request reprint Protective efficacy, immunotherapeutic potential, and safety of hepatitis B vaccines
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines and WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, Royal Free and University College Medical School, University College London, United Kingdom
    J Med Virol 78:169-77. 2006
    ....
  2. doi request reprint Hepatitis B immunisation in travellers: poor risk perception and inadequate protection
    Jane N Zuckerman
    WHO Collaborating Centre for Travel Medicine, The Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, Royal Free Campus, Rowland Hill St, London, NW3 2PF, UK
    Travel Med Infect Dis 6:315-20. 2008
    ..A survey of European travellers was conducted during 2006 to determine travellers' immunisation status and risk for exposure to hepatitis B while travelling...
  3. ncbi request reprint The place of accelerated schedules for hepatitis A and B vaccinations
    Jane Zuckerman
    Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK
    Drugs 63:1779-84. 2003
    ..The primary course may be administered within a period of 1 month so providing protection for those at risk and, in particular, the last minute traveller...
  4. pmc Recent developments: Travel medicine
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, London NW3 2PF
    BMJ 325:260-4. 2002
  5. ncbi request reprint Vaccination priorities in travel
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, University College London, London, UK
    BioDrugs 17:1-6. 2003
  6. ncbi request reprint Recombinant hepatitis B triple antigen vaccine: Hepacare
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, University College of London, UK
    Expert Rev Vaccines 1:141-4. 2002
    ..The triple antigen is indicated for vaccination of nonresponders (and hyporesponders) to the current single antigen vaccines and for persons who require rapid protection against hepatitis B infection...
  7. ncbi request reprint Hepatitis B vaccination in a school age population: a feasibility study
    Jane Zuckerman
    Academic Centre for Travel Medicine and Vaccines, WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, Royal Free and University College Medical School, London, United Kingdom
    J Med Virol 76:47-54. 2005
    ..A further requirement includes the availability of good local health support within schools so as to allow for an efficient vaccine delivery system to maximize vaccination in this setting...
  8. ncbi request reprint Mutations of the surface protein of hepatitis B virus
    Jane N Zuckerman
    Research and Training in Travel Medicine, Royal Free and University College Medical School, University College London, London, UK
    Antiviral Res 60:75-8. 2003
    ..There is evidence that these mutants may not be detected by current screening tests and diagnostic reagents. Epidemiological monitoring of hepatitis B virus surface mutants is essential...
  9. ncbi request reprint Effects of enzyme replacement therapy on the cardiomyopathy of Anderson-Fabry disease: a randomised, double-blind, placebo-controlled clinical trial of agalsidase alfa
    D A Hughes
    Department of Academic Haematology, Royal Free and University College Medical School, Rowland Hill Street, London NW3 2PF, UK
    Heart 94:153-8. 2008
    ..The present study was designed to assess the safety and efficacy of enzyme replacement therapy with agalsidase alfa on the cardiac manifestations of Anderson-Fabry disease...
  10. ncbi request reprint Hearing improvement in patients with Fabry disease treated with agalsidase alfa
    D Hajioff
    Department of Otolaryngology, Royal Free Hospital, London, UK
    Acta Paediatr Suppl 92:28-30; discussion 27. 2003
    ..To describe the nature and prevalence of hearing loss in Fabry disease, and its response to enzyme replacement therapy (ERT) with agalsidase alfa...
  11. doi request reprint Introduction to the Second International Conference of the Journal of Travel Medicine and Infectious Disease
    Jane N Zuckerman
    Travel Med Infect Dis 6:171-2. 2008
  12. ncbi request reprint Vaccination against hepatitis A and B: developments, deployment and delusions
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines and the WHO Collaborating Centre for Reference, Research and Training in Travel Medicine, Royal Free and University College Medical School, London, UK
    Curr Opin Infect Dis 19:456-9. 2006
    ....
  13. ncbi request reprint Immunogenicity and safety of an experimental adjuvanted hepatitis B candidate vaccine in liver transplant patients
    Frederik Nevens
    Department of Hepatology, University Hospital Gasthuisberg K U Leuven, Leuven, Belgium
    Liver Transpl 12:1489-95. 2006
    ..Liver transplant candidates could benefit from the use of this experimental adjuvanted HB vaccine to further increase their protection against HB infection...
  14. ncbi request reprint Hepatitis A and B booster recommendations: implications for travelers
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines and Royal Free Travel Health Centre, World Health Organization Collaborating Centre for Travel Medicine, Royal Free and University College Medical School, London, United Kingdom
    Clin Infect Dis 41:1020-6. 2005
    ..However, for the majority of immunocompetent travelers, the full primary vaccination course will provide protection from both hepatitis A and B infection in the long term, without the need for boosters...
  15. pmc Preventing malaria in UK travellers
    Jane N Zuckerman
    BMJ 329:305-6. 2004
  16. ncbi request reprint Rapid protection against hepatitis A and B using an accelerated vaccination schedule: comparison of combined vaccine, Twinrix, with separate vaccines
    Hans D Nothdurft
    Department of Infectious Diseases and Tropical Medicine, Ludwig Maximilians University, Munich, Germany
    BioDrugs 17:15-8. 2003
  17. ncbi request reprint Enhancement of humoral immune responses to a human cytomegalovirus DNA vaccine: adjuvant effects of aluminum phosphate and CpG oligodeoxynucleotides
    Nigel J Temperton
    Department of Virology, Royal Free and University College Medical School, London, United Kingdom
    J Med Virol 70:86-90. 2003
    ..The results provide a rationale for evaluating combinations of other HCMV proteins for incorporation into a multi-target DNA vaccine, and for the optimization of adjuvant usage, to elicit enhanced levels of neutralizing antibodies. 2003...
  18. ncbi request reprint The true burden and risk of cholera: implications for prevention and control
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines, WHO Collaborating Centre for Travel Medicine, Royal Free and University College Medical School, London, UK
    Lancet Infect Dis 7:521-30. 2007
    ..However, a vaccine against cholera is now available that has proven efficacy and tolerability in mass vaccination campaigns in low-income countries, and among travellers...
  19. pmc Imported malaria in the UK
    Jane N Zuckerman
    BMJ 337:a135. 2008
  20. ncbi request reprint HIV and travel
    M A Schuhwerk
    Department of Genito Urinary Medicine, Mortimer Market Centre, Camden Primary Care Trust NHS, London, UK
    Travel Med Infect Dis 4:174-83. 2006
    ..A wide range of relevant issues for the HIV-positive traveller are discussed in this review and useful websites can be found at the end...
  21. ncbi request reprint Vaccine advice for travellers
    Jane N Zuckerman
    Academic Centre for Travel Medicine and Vaccines
    Practitioner 249:286-90. 2005
  22. ncbi request reprint Impact of the insect biting nuisance on a British youth expedition to Alaska
    Fiona J Cooke
    Academic Centre for Travel Medicine and Vaccines, Royal Free and University College Medical School, London, United Kingdom
    J Travel Med 9:76-81. 2002
    ..The number of bites and their effects was examined on a 6-week British youth expedition to Alaska in July/August 1999...